Many efforts have been made to achieve targeted delivery of anticancer drugs to enhance
their efficacy and to reduce their adverse effects. These efforts include the development of …

In the last several decades, the number of people dying from cancer-related deaths has not
reduced significantly despite phenomenal advances in the technologies related to diagnosis …

Background Treatment options for women presenting with triple negative breast cancer
(TNBC) are limited due to the lack of a therapeutic target and as a result, are managed with …

There is a growing body of evidence suggesting that alterations in the adhesion properties
of neoplastic cells endow them with an invasive and migratory phenotype. Indeed, changes …

Breast cancer is one of the most frequently diagnosed cancers that is threatening women's
life. Current clinical treatment regimens for breast cancer often involve neoadjuvant and …

Cytokines are low molecular weight regulatory proteins or glycoprotein that modulates the
intensity and duration of immune response by stimulating or inhibiting the activation …

Cardiovascular disease (CVD) and cancer are leading causes of morbidity and mortality
worldwide. Although conventionally managed as separate disease processes, recent …

Purpose Although most breast cancer patients who receive neoadjuvant chemotherapy
(NCT) have a tumor response, a small proportion experience progressive disease (PD) …

Approximately 8–20% of breast cancer patients receiving neoadjuvant chemotherapy fail to
achieve a measurable response and endure toxic side effects without benefit. Most clinical …

A microflow cytometer was developed that ensheathed the sample (core) fluid on all sides
and interrogated each particle in the sample stream at four different wavelengths. Sheathing …